next generation glp 1 drugs GLP-1 drugs: Foundayo and the future of weight loss, food and beverage New Zepbound-Like GLP-1 Drug Leads

While emerging preclinical research suggests potential anti-inflammatory properties, there is currently no FDA-approved indication for GLP-1 medications in treating Crohn's disease or any inflammatory bowel disease

This is significant, considering that data from Blue Cross Blue Shield found that over 63% of GLP-1 patients from 2014 to 2023 were in this age group

Make Sure ALL of Your Employees are Added to the PAAS Portal

Plus, they dont require fasting for eight hours before taking them

Long-term follow-up after bariatric surgery in a national cohort

All of the 108 participants, evenly divided among men and women, with an average age of about 50 and nearly all White, were seeking to obtain professional help to reduce, control or stop alcohol abuse